Phase II study of the pure non-steroidal antiandrogen nilutamide in prostatic cancer
- 30 September 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (9) , 1100-1104
- https://doi.org/10.1016/0277-5379(91)90301-s
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Pharmacokinetics of Anandron in patients with advanced carcinoma of the prostateCancer Chemotherapy and Pharmacology, 1988
- Clinical Evaluation with Long-Term Follow-Up of Flutamide and Estramustine as Initial Treatment of Metastatic Carcinoma of the ProstateAmerican Journal of Clinical Oncology, 1988
- Comparison of Diethylstilbestrol, Cyproterone Acetate and Medroxyprogesterone Acetate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Randomized Phase III Trial of the European Organization for Research on Treatment of Cancer Urological GroupJournal of Urology, 1986
- Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancerJournal of Steroid Biochemistry, 1986
- Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetateMolecular and Cellular Endocrinology, 1985
- Comparison of Prostatic Cancer Tissue Dihydrotestosterone Levels at the Time of Relapse Following Orchiectomy or Estrogen TherapyJournal of Urology, 1984
- Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapyCancer, 1984
- Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissuesJournal of Steroid Biochemistry, 1979
- STEROIDS OF ADRENAL ORIGIN METABOLIZED BY HUMAN PROSTATIC TISSUE BOTH IN VIVO AND IN VITROJournal of Endocrinology, 1974